: BPC-157 , (, )
Compounded BPC-157 from a 503A pharmacy requires a valid prescription from a licensed prescriber and depends on the compounding classification outcome
Cancer Res 66 : 1129811304 Gore SD, Baylin S, Sugar E, Carraway H, Miller CB, Carducci M, Grever M, Galm O, Dauses T, Karp JE, Rudek MA, Zhao M, Smith BD, Manning J, Jiemjit A, Dover G, Mays A, Zwiebel J, Murgo A, Weng LJ, Herman JG (2006) Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
Therefore, if epitalon binds to and inhibits H1.3 in the cancer cells, H19 would be derepressed
It is an anti-ulcer peptide (9-12), interacting with NO-system (13), and, unlike other peptides, it is particularly stable in gastric juice (14) and is used consistently without a carrier (9-11, 13-24), being safe in patients with the inflammatory bowel disease (coded PL-10, PLD 116, PL 14736) (21)
The risks to consider when using BPC-157 for Gut Healing are listed below